Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Callon Petroleum Company is an independent oil and natural gas company. The Zacks Consensus Estimate for its current year earnings has been revised 3.4% downward over the last 30 days.
Exelixis, Inc. (EXEL - Free Report) engages to discover, develop and commercialize new medicines in order to enhance care and outcomes for cancer patients. The Zacks Consensus Estimate for its current year earnings has been revised 4.8% downward over the last 30 days.
Livent Corporation manufactures and markets performance lithium compounds used chiefly in specialty polymers, energy storage and chemical synthesis application. The Zacks Consensus Estimate for its current year earnings has been revised 0.9% downward over the last 30 days.
Natus Medical Incorporated offers products and services in areas of newborn care, neurology and hearing and balance assessment healthcare. The Zacks Consensus Estimate for its current year earnings has been revised 1.7% downward over the last 30 days.
USG Corporation (USG - Free Report) manufactures and markets building materials. The Zacks Consensus Estimate for its current year earnings has been revised 3.2% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Callon Petroleum Company is an independent oil and natural gas company. The Zacks Consensus Estimate for its current year earnings has been revised 3.4% downward over the last 30 days.
Exelixis, Inc. (EXEL - Free Report) engages to discover, develop and commercialize new medicines in order to enhance care and outcomes for cancer patients. The Zacks Consensus Estimate for its current year earnings has been revised 4.8% downward over the last 30 days.
Livent Corporation manufactures and markets performance lithium compounds used chiefly in specialty polymers, energy storage and chemical synthesis application. The Zacks Consensus Estimate for its current year earnings has been revised 0.9% downward over the last 30 days.
Natus Medical Incorporated offers products and services in areas of newborn care, neurology and hearing and balance assessment healthcare. The Zacks Consensus Estimate for its current year earnings has been revised 1.7% downward over the last 30 days.
USG Corporation (USG - Free Report) manufactures and markets building materials. The Zacks Consensus Estimate for its current year earnings has been revised 3.2% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on EXEL - FREE
Get the latest research report on USG - FREE